Russia approves the plan for Development of Biotechnology and Genetic Engineering

13 March 2018

GMP News

The Russian government adopted the action plan (roadmap) for the Development of Biotechnology and Genetic Engineering in 2018 – 2020.

The plan aims at developing domestic demand, manufacturing and exports of biotech products, and building institutional environment in order to modernize the technology base of the industry through mass introduction of biotech methods and products.

It provides for further expansion of production potential and cooperation in the area of biomedicine and biopharmaceuticals, agricultural and industrial biotechnology, bioenergetics, forest and environmental biotechnology, and genetic engineering.

By 2020, 2 common use production centers licensed for manufacturing biomedical cell products will be established to conduct R&D and pre-clinical studies of biomedical cell products.

The number of medical institutions accredited for clinical trials of biomedical cell products will be increased from 5 to 50.

Previous publication Next publication

Media Center

  • 20 March 2018

    Russia establishes its National Quality Infrastructure Council

    On March 14, Denis Manturov, the Russian Minister of Industry and Trade, chaired a meeting of the State Commission on Counteraction to Illegal Circulation of Industrial Products. The Minister said that, ensuring the “market purity” would require, in addition to providing more preferences for entrepreneurs operating strictly within the legal field, to guarantee to potential consumers that they purchase genuine rather than counterfeit and falsified products.

  • 20 March 2018

    Researchers in aging tie genes to brain degeneration

    As brain cells age, they lose their ability to perform basic functions, often leading to dementia and other neurodegenerative disorders. But what’s behind this decline, and can it be stopped? Two new studies out this week uncover links between genes and brain-cell functioning that could provide new targets for therapies aimed at neurodegenerative diseases.

  • 19 March 2018

    China established a new drug regulator

    After about five years as a standalone agency, the China Food and Drug Administration (CFDA) will merge into a gigantic national market supervision administration, with drug regulation as a new, second-tier bureau underneath.

  • 19 March 2018

    Project of EAEU unified goods traceability system was presented to the public

    The unified goods traceability system in the Eurasian Economic Union (EAEU) will provide consumers with access to reliable information about products, allow businesses to reduce their transaction costs, let member states to monitor the payment of taxes, minimize smuggling, and protect consumers.

Read more